SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,424,000 | -0.4% | 395,044 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $4,441,000 | +12.6% | 403,714 | +0.3% | 0.00% | -20.0% |
| Q1 2017 | $3,945,000 | -5.3% | 402,500 | +4.4% | 0.01% | 0.0% |
| Q4 2016 | $4,165,000 | +11.9% | 385,658 | +6.2% | 0.01% | 0.0% |
| Q3 2016 | $3,723,000 | -18.8% | 363,174 | +3.4% | 0.01% | -16.7% |
| Q2 2016 | $4,587,000 | +3323.1% | 351,202 | +2475.7% | 0.01% | – |
| Q2 2015 | $134,000 | +3.9% | 13,635 | -6.5% | 0.00% | – |
| Q1 2015 | $129,000 | +4.0% | 14,584 | +3.2% | 0.00% | – |
| Q4 2014 | $124,000 | -3.1% | 14,138 | -23.7% | 0.00% | – |
| Q3 2014 | $128,000 | +32.0% | 18,531 | 0.0% | 0.00% | – |
| Q2 2014 | $97,000 | -15.7% | 18,531 | -26.4% | 0.00% | – |
| Q1 2014 | $115,000 | -10.2% | 25,166 | -1.2% | 0.00% | – |
| Q4 2013 | $128,000 | -1.5% | 25,472 | -0.4% | 0.00% | – |
| Q3 2013 | $130,000 | -3.7% | 25,586 | -6.1% | 0.00% | – |
| Q2 2013 | $135,000 | – | 27,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |